KLRS

Kalaris Therapeutics, Inc. is a clinical-stage biotechnology company based in Palo Alto, California, focused on pioneering therapies for neovascular retinal diseases, an area marked by significant unmet medical needs. The company leverages cutting-edge research and development to create transformative therapies designed to enhance patient outcomes in ocular health. With a robust product pipeline and a team of experienced professionals, Kalaris is strategically positioned to advance innovative solutions in the ophthalmology sector, navigating the competitive biotechnology landscape to drive growth and improve healthcare solutions.